| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.04. | Aptevo Therapeutics Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.04. | Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering | 232 | ACCESSWIRE | SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary... ► Artikel lesen | |
| 11.04. | Why Aptevo Therapeutics Stock Is Cratering | 7 | Benzinga.com | ||
| 11.04. | Aptevo Therapeutics slumps after discounted equity raise | 8 | Seeking Alpha | ||
| 11.04. | Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today? | 6 | InvestorPlace | ||
| 11.04. | Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering | 189 | ACCESSWIRE | SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary... ► Artikel lesen | |
| 10.04. | Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare movers | 10 | Seeking Alpha | ||
| 10.04. | Aptevo Therapeutics Provides Pipeline Update | 146 | ACCESSWIRE | Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the... ► Artikel lesen | |
| 09.04. | Aptevo Therapeutics Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 29.03. | Aptevo Therapeutics Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 20.03. | Aptevo Therapeutics Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 18.03. | Aptevo Therapeutics: Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference | 300 | ACCESSWIRE | SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary... ► Artikel lesen | |
| 08.03. | Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers | 10 | Seeking Alpha | ||
| 07.03. | Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday? | 5 | Benzinga.com | ||
| 07.03. | Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4 | 236 | ACCESSWIRE | Initial interim data show favorable drug exposure and confirm ALG.APV-527 biological activityEarly promising signs of clinical activity in heavily pretreated patientsDose-escalation trial data on track... ► Artikel lesen | |
| 05.03. | Aptevo Therapeutics: Q4 Earnings Insights | 6 | Benzinga.com | ||
| 05.03. | Aptevo Therapeutics Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 05.03. | Aptevo Therapeutics Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 05.03. | Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update | 258 | ACCESSWIRE | Announces 1H24 Plan for Development of Lead Candidate APVO436 for the Treatment of Frontline Acute Myeloid Leukemia, Interim Results Expected Late 2H24ALG.APV-527 Phase 1 Trial for the Treatment of... ► Artikel lesen | |
| 04.03. | Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan | 235 | ACCESSWIRE | SEATTLE, WA / ACCESSWIRE / March 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.683 |
| SUPER MICRO COMPUTER | 1.854 |
| BAYER | 1.590 |
| BYD | 1.339 |
| AMAZON | 1.249 |
| NVIDIA | 1.226 |
| DEUTSCHE BANK | 1.125 |
| NEL | 1.058 |
| TESLA | 1.035 |
| TUI | 1.025 |
| PFIZER | 861 |
| MERCEDES-BENZ | 768 |
| CANOPY GROWTH | 716 |
| AMD | 688 |
| VOLKSWAGEN | 665 |
| COMMERZBANK | 659 |
| PAYPAL | 651 |
| STARBUCKS | 633 |
| NOVO NORDISK | 591 |
| PLUG POWER | 569 |
| AIXTRON SE | 557 |
| BARRICK GOLD | 546 |
| RHEINMETALL | 499 |
| AURORA CANNABIS | 494 |
| DEUTSCHE LUFTHANSA | 479 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
